选择语言

Glycoprotein (RABV)

Glycoprotein (RABV)信息

英文名称:Thrombospondin 1上市药物数量0
中文名称血小板1临床药物数量2
靶点别称TSP,Glycoprotein G,THBS1,Thrombospondin-1p180,TSP1,Thrombospondin-P50,Thrombospondin-1,THBS-1,TSP-1,THBS,Thrombospondin 1最高研发阶段临床三期
英文名称:Thrombospondin 1
中文名称血小板1
靶点别称TSP,Glycoprotein G,THBS1,Thrombospondin-1p180,TSP1,Thrombospondin-P50,Thrombospondin-1,THBS-1,TSP-1,THBS,Thrombospondin 1
上市药物数量0
临床药物数量2
最高研发阶段Phase 3 Clinical

产品咨询

Glycoprotein (RABV)分子背景

Rabies virus (RABV), scientific name Rabies lyssavirus, is a deadly neurotropic virus that causes rabies in humans and animals. Rabies virus has an extremely wide host range and its transmission most often occur through the saliva of animals. Without intervention prior to disease progression, rabies has the highest case fatality of any infectious disease. RABV contains a single-stranded negative-sense RNA genome that encodes five structural proteins: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and RNA-dependent RNA polymerase (L). Among these viral proteins, the RABV glycoprotein (RABV-G) is a pivotal player mediating virus entry and the major target of neutralizing antibodies, thus a key factor for vaccine and drug design.

Glycoprotein (RABV)分子别名

Glycoprotein G
  • 分子信息
  • 产品咨询